Priya Karmali

Salesforce Outlook Microsoft Office 365 WordPress.org Mobile Friendly Google Analytics Google Tag Manager AI Remote

biotechnology research targeted lipid nanoparticles in vivo rna delivery car-t therapy mrna engineering gene editing tools therapeutic possibilities disease-specific payloads autoimmune disorders oncology applications fibrosis treatment monogenic blood disorders immunology cell reprogramming biologic therapies rna-based therapies lipid nanoparticle technology immune system reset b cell depletion t cell engineering cd8+ t cells translational medicine clinical trials scalable manufacturing pharmacokinetics non-viral delivery system biopharmaceutical innovation patient-centric therapies drug development therapeutic modalities cell type-specific targeting scalable biotechnology solutions immune cell modulation ethics in biomedicine clinical proof-of-concept early disease intervention dosing protocols research & development biotech investment leadership in biotechnology biotechnology startups therapeutic advancements preclinical studies scientific discovery drug-like safety profiles molecular targeting independent research institutions biotechnology collaboration transformative therapies cell & gene therapy biotechnology targeted rna delivery in vivo cell engineering tlnp technology gene editing oncology fibrosis precision medicine patient-centric innovation rna technologies cell therapy genetic medicine modular therapeutic design clinical development unmet medical needs diverse disease focus collaboration resilience dei commitment preclinical data investor financing healthcare partnerships health care health wellness & fitness hospital & health care